Cited by 791Cardiomyopathy and Myosin StudiesCardiac electrophysiology and arrhythmiasCardiovascular Effects of Exercise

The DOI matches its Crossref record, with a small difference in title or year; 171 of the 172 references it cites were found in a registry or an index.

Dilated Cardiomyopathy: Genetic Determinants and Mechanisms

Open access

McNally, Elizabeth M., Mestroni, Luisa·2017·Circulation Research

DOI 10.1161/circresaha.116.309396PMC PMC5626020

Open this paper in CoChat — free account

Abstract

Nonischemic dilated cardiomyopathy (DCM) often has a genetic pathogenesis. Because of the large number of genes and alleles attributed to DCM, comprehensive genetic testing encompasses ever-increasing gene panels. Genetic diagnosis can help predict prognosis, especially with regard to arrhythmia risk for certain subtypes. Moreover, cascade genetic testing in family members can identify those who are at risk or with early stage disease, offering the opportunity for early intervention. This review will address diagnosis and management of DCM, including the role of genetic evaluation. We will also overview distinct genetic pathways linked to DCM and their pathogenetic mechanisms. Historically, cardiac morphology has been used to classify cardiomyopathy subtypes. Determining genetic variants is emerging as an additional adjunct to help further refine subtypes of DCM, especially where arrhythmia risk is increased, and ultimately contribute to clinical management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circresaha.116.309396

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Contemporary Definitions and Classification of the Cardiomyopathies
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,715
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Authors Task Force Members, Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, J. A., Elliot, P. M., Fitzsimons, D., Hatala, R., et al. (2015) · EP Europace · doi:10.1093/europace/euv319 · Cited by 1,671
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Self-citation

Show all 172 references

Research works printed but not linked: 2

10.1172/JCI19670 · DOI
MacRae C, Taylor MRG, Mestroni L, Moses JR, Ashley EA, Wheeler MT, Lakdawala NK, Hershberger RE, Ptaszynski M, Sandor V, Saunders ME, Oliver C, Lee PA, Judge DP. Phase 2 study of a797, an oral, selective p38 mitogen-activated protein kinase inhibitor, in patients with lamin a/c-related dilated cardiomyopathy. Eur Heart J. 2016;37:1011.

Sorted by citations

Items 701–791 of 791

Deregulated nutrient response in ttntv cardiomyopathy can be repaired via Erk inhibition for cardioprotective effects
Yan, F., Wang, W., Moossavi, M., Zhu, P., Noa, O., & Xu, X. (2025) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2025.100347
Cardiac Troponin C E135A Variant Impairs Myofilament Response to PKA Phosphorylation and Is Associated With Autosomal Dominant Dilated Cardiomyopathy With Diastolic Dysfunction
Landim-Vieira, M., Perelli, R. M., Garcia, M. R., Jani, V., Chastain, R., Lamar, J. H., Mines, E., Seo, G., Fernandes, A. A., Knollmann, B. C., et al. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.124.004720
TTN-Related Dilated Cardiomyopathy in a Patient with Positive Unknown Familiarity for Heart Failure and Bicuspid Aortic Valve
Sarzilla, S., Rigamonti, E., Leo, L. A., Scopigni, F. R., & Moschovitis, G. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15360
Heart Regeneration With Stem Cell Therapies
Clavellina, D., Marasigan, N., Balkan, W., & Hare, J. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00056-x
Cellular models of chronic diseases: From bench to bedside
Tiwari, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33877-9.00015-x
Safety and efficacy of SGLT2i administration in dilated cardiomyopathy: protocol for a systematic review and meta-analysis
Hu, R., Yu, L., Li, J., Liu, L., & Li, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1575493
Génétique des cardiomyopathies héréditaires
Richard, P., Ader, F., & Charron, P. (2025) · EMC - Cardiologie · doi:10.1016/s1166-4568(24)48547-1
From molecular and cellular mechanisms to models of heart failure
Lombardi, R., Peña, B., Medo, K., Taylor, M. R. G., & Mestroni, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13279-7.00025-0
Self-citation
Cardiomyocyte Nuclear Pleomorphism in a Mouse Model of Inherited Hypertrophic Cardiomyopathy
Johnston, J. R., Coscarella, I. L., Rose, C. L., Shi, Y., Rastegarpouyani, H., Jones, K. M. D., Patourel, J. M. L., Ogunfuwa, F., Martins, A. S., Crotty, K. M., et al. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12110449
Severe Cardiomegaly in Congestive Heart Failure
Mote, T. R., Scroggins, C. T., Gillett, A., & Yoakum, C. B. (2025) · JACC Case Reports · doi:10.1016/j.jaccas.2025.105822
Metabolic Modulation in Dilated Cardiomyopathy: From Pathophysiology to Therapy
Nie, X., & Lu, Z. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm45518
Identification and Validation of RNA Modification-Related Biomarkers in Dilated cardiomyopathyPreprint
Wang, Z., Fang, X., Wang, X., Liu, L., & Yao, L. (2025) · Research Square · doi:10.21203/rs.3.rs-8221884/v1
Cardiomyopathies
Berliner, D., Sonnenschein, K., & Bauersachs, J. K. (2025) · Springer eBooks · doi:10.1007/978-3-662-69938-6_24
Functional characterization of a novel JPH2 variant (p.R160H) associated with dilated cardiomyopathy
Jiao, K., Gong, K., Luo, Y., Liu, R., Wang, L., Yao, Y., & Xie, L. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05443-8
Additional file 7 of Genomic analysis of circular RNAs in heart
Dong, K., He, X., Huabo, S., Fulton, D. J. R., & Zhou, J. (2020) · Figshare · doi:10.6084/m9.figshare.13204514
Additional file 1 of Dilated cardiomyopathy caused by a pathogenic nucleotide variant in RBM20 in an Iranian family
Malakootian, M., Moghaddam, M. B., Kalayinia, S., Farrashi, M., Maleki, M., Sadeghipour, P., & Amin, A. (2022) · Figshare · doi:10.6084/m9.figshare.19731779
Additional file 3 of Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy
Wang, Y., Xie, Y., Mahara, G., Xiong, Y., Xiong, Y., Zheng, Q., Chen, J., Zhang, W., Zhou, H., & Li, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26670999
Additional file 1 of Identification and functional characterization of BICD2 as a candidate disease gene in an consanguineous family with dilated cardiomyopathy
Luo, K., Zheng, C., Luo, R., Cao, X., Sun, H., Ma, H., Huang, J., Yang, X., Wu, X., & Li, X. (2022) · Figshare · doi:10.6084/m9.figshare.21009581
Additional file 9 of Genomic analysis of circular RNAs in heart
Dong, K., He, X., Huabo, S., Fulton, D. J. R., & Zhou, J. (2020) · Figshare · doi:10.6084/m9.figshare.13204520
Additional file 8 of Genomic analysis of circular RNAs in heart
Dong, K., He, X., Huabo, S., Fulton, D. J. R., & Zhou, J. (2020) · Figshare · doi:10.6084/m9.figshare.13204517
Additional file 1 of Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq
Fang, C., Lv, Z., Yu, Z., Wang, K., Xu, C., Li, Y., & Wang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20336809
Additional file 2 of Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing
Lian, H., Song, S., Chen, W., Shi, A., Jiang, H., & Hu, S. (2023) · Figshare · doi:10.6084/m9.figshare.23700791
Additional file 4 of Genomic analysis of circular RNAs in heart
Dong, K., He, X., Huabo, S., Fulton, D. J. R., & Zhou, J. (2020) · Figshare · doi:10.6084/m9.figshare.13204505
Additional file 1 of Functional enrichment of alternative splicing events with NEASE reveals insights into tissue identity and diseases
Louadi, Z., Elkjaer, M. L., Klug, M., Lio, C. T., Fenn, A. M., Illés, Z., Bongiovanni, D., Baumbach, J., Kacprowski, T., List, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17120378
Additional file 1 of Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing
Lian, H., Song, S., Chen, W., Shi, A., Jiang, H., & Hu, S. (2023) · Figshare · doi:10.6084/m9.figshare.23700788
Additional file 2 of Association of uncertain significance genetic variants with myocardial mechanics and morphometrics in patients with nonischemic dilated cardiomyopathy
Ankudavičė, K. M. , Šukys, M., Kasputytė, G., Krikštolaitis, R., Ereminienė, E., Galnaitienė, G., Mizarienė, V., Šakalytė, G., Krilavičius, T., & Jurkevičius, R. (2024) · Figshare · doi:10.6084/m9.figshare.26711846
Additional file 1 of Stigma manifestations in cardiomyopathy care impact outcomes for black patients: a qualitative study
Wolfgang, M., Beskow, L. M., Hooker, G. W., Roberson, M. L., & Anderson, K. C. (2024) · Figshare · doi:10.6084/m9.figshare.26638530
Additional file 5 of Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy
Wang, Y., Xie, Y., Mahara, G., Xiong, Y., Xiong, Y., Zheng, Q., Chen, J., Zhang, W., Zhou, H., & Li, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26671005
Additional file 8 of Functional enrichment of alternative splicing events with NEASE reveals insights into tissue identity and diseases
Louadi, Z., Elkjaer, M. L., Klug, M., Lio, C. T., Fenn, A. M., Illés, Z., Bongiovanni, D., Baumbach, J., Kacprowski, T., List, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17120420
Additional file 15 of Genomic analysis of circular RNAs in heart
Dong, K., He, X., Huabo, S., Fulton, D. J. R., & Zhou, J. (2020) · Figshare · doi:10.6084/m9.figshare.13204493
Additional file 1 of Association of uncertain significance genetic variants with myocardial mechanics and morphometrics in patients with nonischemic dilated cardiomyopathy
Ankudavičė, K. M. , Šukys, M., Kasputytė, G., Krikštolaitis, R., Ereminienė, E., Galnaitienė, G., Mizarienė, V., Šakalytė, G., Krilavičius, T., & Jurkevičius, R. (2024) · Figshare · doi:10.6084/m9.figshare.26711843
Additional file 2 of Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy
Wang, Y., Xie, Y., Mahara, G., Xiong, Y., Xiong, Y., Zheng, Q., Chen, J., Zhang, W., Zhou, H., & Li, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26670996
Additional file 2 of Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity
Tan, C. Y., Chan, P. S., Tan, H., Tan, S. W., Lee, C. J. M., Wang, J.-W., Ye, S., Werner, H., Loh, Y. J., Lee, Y. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24312982
Additional file 1 of Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy
Wang, Y., Xie, Y., Mahara, G., Xiong, Y., Xiong, Y., Zheng, Q., Chen, J., Zhang, W., Zhou, H., & Li, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26670993
Additional file 2 of Dilated cardiomyopathy caused by a pathogenic nucleotide variant in RBM20 in an Iranian family
Malakootian, M., Moghaddam, M. B., Kalayinia, S., Farrashi, M., Maleki, M., Sadeghipour, P., & Amin, A. (2022) · Figshare · doi:10.6084/m9.figshare.19731782
Additional file 1 of Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity
Tan, C. Y., Chan, P. S., Tan, H., Tan, S. W., Lee, C. J. M., Wang, J.-W., Ye, S., Werner, H., Loh, Y. J., Lee, Y. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24312939
Additional file 12 of Genomic analysis of circular RNAs in heart
Dong, K., He, X., Huabo, S., Fulton, D. J. R., & Zhou, J. (2020) · Figshare · doi:10.6084/m9.figshare.13204484
Additional file 4 of Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy
Wang, Y., Xie, Y., Mahara, G., Xiong, Y., Xiong, Y., Zheng, Q., Chen, J., Zhang, W., Zhou, H., & Li, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26671002
Additional file 1 of Genomic analysis of circular RNAs in heart
Dong, K., He, X., Huabo, S., Fulton, D. J. R., & Zhou, J. (2020) · Figshare · doi:10.6084/m9.figshare.13204496
Additional file 11 of Genomic analysis of circular RNAs in heart
Dong, K., He, X., Huabo, S., Fulton, D. J. R., & Zhou, J. (2020) · Figshare · doi:10.6084/m9.figshare.13204481
Additional file 6 of Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy
Wang, Y., Xie, Y., Mahara, G., Xiong, Y., Xiong, Y., Zheng, Q., Chen, J., Zhang, W., Zhou, H., & Li, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26671008
Idiopathic Dilated Cardiomyopathy in a 14-Year-Old Girl Presenting with Acute Biventricular Heart Failure at Sunyani Teaching Hospital in Ghana: A Case Report
Elisha, A., Alexander, E. K., Edward, B. M., Henry, A. K., Banabas, K., Frank, A.-K., Michael, O., & Maxwell, G. P. (2025) · British journal of healthcare and medical research · doi:10.14738/bjhr.1204.19314
Subgroups and Special Populations in Heart Failure Clinical Trials
Blumer, V. L., Bozkurt, B., Konstam, M. A., Fiuzat, M., Abraham, W. T., Bristow, M. R., Cavagna, I., Cedars, A. M., Greenberg, B., Guilliod, C. R., et al. (2026) · JACC Heart Failure · doi:10.1016/j.jchf.2025.102775
Next generation sequencing in dilated cardiomyopathy: utility and challenges in the African context
Mayisela, M., Mpanya, D., Adamu, U. G., Mpangase, P. T., Lombard, Z., Amoni, J., Mboweni, N., & Tsabedze, N. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1717936
Association of atrial tachyarrhythmia, heart block, and right ventricular dysfunction: a case report and review of literature
Muharram, M., Awad, S. S., Shaaban, A. E. A., & El‐Damaty, A. (2026) · Journal of Medical Case Reports · doi:10.1186/s13256-025-05271-6
MYOM1 deficiency leads to dilated cardiomyopathy by disrupting the homeostasis of sarcoplasmic reticulum
Ruan, J., Guan, Y., Le, K., Zhang, A., Tan, P., Ran, Y., Wu, H., Peng, Y., Wang, Y., Feng, X., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104072
Dilated Cardiomyopathy and Later Onset Limb-Girdle Muscular Dystrophy Associated With Fukutin and Lamin A/C Mutations
Perez, A. C., Moenning, R., Bodkin, C. L., Gutmann, L., Helm, B. M., Wells, L., Moore, S. A., & Ilonze, O. J. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.107038
Neuroticism as a protective factor for cardiomyopathy: A mediation Mendelian randomization study
Wang, M., Teng, T., Mo, D., Chen, R., Xu, J., Dong, Z., Zhang, N., & Yu, H. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121400
A single-center study of the clinical and genetic characteristics of the dilated cardiomyopathy caused by MYH7 gene variants in eighty unrelated children
Burykina, Y. S., Sdvigova, N. A., Basargina, E. N., Globa, O. V., Kurenkov, A. L., Сергеевич, Ж. И., Pushkov, A. A., & Savostyanov, K. V. (2026) · L O Badalyan Neurological Journal · doi:10.46563/2686-8997-2025-6-4-195-208
Experience on Genetic Testing for Primary Dilated Cardiomyopathy in a Single Austrian Genetic Center and the Role of Myocardial Inflammation
Manzanilla-Romero, H. H., Steil, A. S., Santner, V., der Heidt, A. V., Verheyen, N., Pölzl, G., Witsch‐Baumgartner, M., & Rudnik-Schöneborn, S. (2026) · Cardiology · doi:10.1159/000550976
The potential effect of calcium sensitizer in pulmonary hypertension post-coronavirus disease-19 infection in presumptive familial dilated cardiomyopathy: a case report
Andryan, D. P., Hasanah, D. Y., & Atmadikoesoemah, C. A. (2026) · Journal of Medical Case Reports · doi:10.1186/s13256-026-05854-x
From gene to heart: the impact of a novel SGCD variant in familial dilated cardiomyopathy
Kalayinia, S., Poopak, A., Soveizi, M., & Maleki, M. (2026) · BMC Medical Genomics · doi:10.1186/s12920-026-02342-5
Fasting reverses PLN R14del-mediated cardiomyopathy through lysosomal reactivationPreprint
Gooijers, I., Arning, A., de Heus, C., Heins-Marroquin, U., Nguyen, P. D., Honkoop, H., Verhagen, T., Mokhles, M. M., Riele, A. S. J. M. T., Harakaľová, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.24.713684
Advances in Research on Dilated Cardiomyopathy
谭, 瑶. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1641267
Experimental Biology and Medicine Volume 251 Issue 3
(2026) · Frontiers Media SA eBooks · doi:10.3389/978-2-8325-7770-7
Burden, spectrum, and treatment gaps in cardiac diseases in Ethiopia: an 11-year analysis of 10,999 patients at a National Charity Cardiac Center
Nasir, M., Markos, S., Mengistu, M., & Dejene, K. (2026) · BMC Research Notes · doi:10.1186/s13104-026-07799-2
Cardiac manifestations of inherited metabolic disease linked to cellular metabolism of vitamin B12 : study in two murine models of invalidation of Mtr and MMACHC genes
Kosgei, V. J. (2019) · doi:10.70675/f3a31948zabb5z4be0z8f59zbcac02c1cd4d
Exploration of altered molecular pathways involved in pathophysiology of LMNA-cardiomyopathy
Rodríguez, B. M. (2018) · theses.fr (ABES) · doi:10.70675/4ae5ce5cz0a8dz44d7z9c3bzf990ea66223b
Effets de l’exercice et d’une modulation du métabolisme du NAD sur la fonction cardiaque et musculaire dans la cardiomyopathie dilatée
Deloux, R. (2018) · theses.fr (ABES) · doi:10.70675/187a7874z7c88z4ab7z9392zc08078be5b17
Modélisation cardiaque des myopathies myofibrillaires à l'aide de cellules souches pluripotentes induites pour explorer la pathogenèse cardiaque
Hovhannisyan, Y. (2020) · theses.fr (ABES) · doi:10.70675/51802621ze379z4aaaza16ez60804363a248
Identification of CCL2, CCL5, and TAGLN macromolecules as diagnostic biomarkers for dilated cardiomyopathy through electrochemical sensor analysis: Aging-Associated Immune Dysregulation and Fibrosis
Liu, W., Sun, M., Xu, S., Li, Z., Tian, J., & Zhao, X. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.118268
Genotype–Phenotype Discordance in Cardiomyopathies: Pathophysiology, Clinical Expression, and Therapeutic Considerations
Nazir, A., Sarwar, A. H., Nazar, R., Shahab, S. H., Manan, S., Rafique, H., Khan, A. T., Shubietah, A. R. M., Zaidi, S. R. H., & Khan, B. (2026) · Health Science Reports · doi:10.1002/hsr2.72398
Decoding the Mitochondrial Translation-Stress Axis
Zeldin, S., & Sadoshima, J. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101565
The role of cardiac myosin activators in dilated cardiomyopathy pharmacotherapy
Garcia, E. S., Taylor, M. R. G., Mestroni, L., & Lombardi, R. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2682840
Self-citation
Cardiomyocyte programmed cell death in dilated cardiomyopathy: molecular crosstalk and therapeutic implications
Qiu, Y., & Chen, Z. R. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1815510
Heart Failure: An Updated Review of Classification, Etiology, and Pathophysiology
Bensimhon, H. F., & Min, D. B. (2026) · International Journal of Angiology · doi:10.1055/a-2856-4635
A large-scale single-nucleus resource reveals a cardiomyocyte-like fibroblast and stage-specific remodeling across cardiomyopathies
Tang, Q., Li, X., Fan, X., Zheng, C., Ma, H., Luo, R., Tang, Y., Liu, S., Fan, C., Zhang, Y., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04954-1
Epigenetic and chromatin remodeling mechanisms across cardiomyopathies: a comprehensive review
Upadhyaya, P. (2026) · Epigenetics & Chromatin · doi:10.1186/s13072-026-00681-2
Cardioprotective Effects of 1,3 Butanediol in MASLD via Reversal of Cardiac Lipid Accumulation and Suppression of Cardiac Fibrosis
Badmus, O. O., Parrow, L. D., McGowen, K. E., Bell, L., Greer, J. R., Cruz, M. D. C., Hinds, T. D., & Stec, D. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125354
Targeting intracellular cholesterol imbalance rescues sarcomere–ER contact site signaling and ER remodeling in dilated cardiomyopathy
Ignatyeva, N., Cheruiyot, C., Saleem, H. N., Wali, R., Plota, D., Zhang, W., Schön, S., Brandenburg, S., Yang, Z., Steyer, A. M., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02731-3
Genetic Basis of Dilated Cardiomyopathy: Recent Evidence and Further Challenges
Vitanova, K., Tzveova, R., Yaneva-Sirakova, T., Shumkova, М., Dimova, I., & Kaneva, Р. (2026) · Acta Medica Bulgarica · doi:10.2478/amb-2026-0062
Assessing Quality of Life in Genetic Cardiomyopathies: A Scoping Review
Tomberli, L., Barlocco, F., Koivu, A. M., Hyttinen, J., Olivotto, I., & Ciucci, E. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23070833
CRISPR-Engineered hiPSC-derived Cardiomyocytes Reveal Divergent Responses to Loss and Defective Processing of A-type LaminsPreprint
Vandeweyer, L., Garrido-Huescar, E., Vandenputte, M., Vandendriessche, B., Alaerts, M., Ordovás, L., Loeys, B., & Vos, W. H. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.29.735225
Nadir Hastalıkların Klinik Sistem Temelli Sınıflandırılması: Modern Moleküler Biyoloji, Sistem Biyolojisi ve Translasyonel Tıp Perspektifleri
Bayramcı, N. S., & Demirkaya, R. (2026) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub1358.c5470
Nadir Hastalıklarda Kalıtım Modelleri: Moleküler Patogenez, Genotip–Fenotip İlişkileri ve Hassas Tıp Perspektifleri
Bayramcı, N. S., & Yavuz, D. (2026) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub1358.c5468
Urokinase-type plasminogen activator, WNT signaling, and brain natriuretic peptide in heart failure patients with end-stage kidney disease
Salim, R. F., Alfatlawi, W. R., & Aldabagh, M. A. H. (2026) · AIP conference proceedings · doi:10.1063/5.0329992
Ankyrin Repeat Domain 1: A Key Regulatory Factor and Emerging Therapeutic Target in Heart Disease
Wang, Z., Du, Q., & Zhang, S. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm48749
MicroRNAs in dilated cardiomyopathy: from biomarkers to therapeutic targets
S, A. V. J. V., Sandra, P. S. S., Vasu, M. M., Jeemon, P., Ganapathi, S., Urulangodi, M., Mohan, N., Kumar, P. R. A., Ambatipudi, S., Vijay, J., et al. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12573-5
Cardiac-Predominant Fukutinopathy Caused by Novel Compound Heterozygous FKTN Variants
Imayavaramban, B., kumar, P., Chowdhury, R. R., Harish, P., Lone, M. Y., Nagesh, S., Sreedharan, S. E., & Namboodiri, N. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.110209
Alternative splicing remodeling and splicing factor regulatory networks define immune-associated molecular heterogeneity in dilated cardiomyopathy
Li, J., He, Y., Zhao, X., Guo, Z., Song, J., & Song, X. (2026) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2026.1934275
Genetic testing for dilated and arrhythmogenic cardiomyopathies – A primer for cardiologists
Dillon, J. C., Arora, S., & Kalra, D. K. (2026) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2026.09.002
The Multifaceted Role of the FLNC Gene in Hereditary Cardiomyopathies and Prognosis
D’Apolito, M., Ranaldi, A., Gaudiano, T., Maffione, A. B., Santacroce, R., D’Andrea, G., Iacoviello, M., & Margaglione, M. (2026) · Genes · doi:10.3390/genes17091136
Hyperfused stress-resistant mitochondria in E161K LMNA mutation associated with dilated cardiomyopathyPreprint
Tomaskova, Z. S., Kšiňanová, M., Jurkovičová-Tarabová, B., Kirnagova, A., Bortoli, M. D., Zacchigna, S., & Danko, K. (2026) · Research Square · doi:10.21203/rs.3.rs-10856026/v1
Superior 5-Year Survival in Heart Transplant Recipients with Pre-Transplant Dilated Cardiomyopathy Versus Ischemic Cardiomyopathy
Haag, A., Rivinius, R., Helmschrott, M., Rahm, A., Ehlermann, P., Frey, N., & Darche, F. F. (2026) · Diagnostics · doi:10.3390/diagnostics16183032
General Aspects of Genetics in Cardiomyopathies
Ferro, M. D., Paldino, A., Salvador, A., Girotto, G., Gasparini, P., D’Adamo, P., & Sinagra, G. (2026) · Springer eBooks · doi:10.1007/978-3-032-34334-5_3
Evaluation of right ventricular function by echocardiography, including speckle echocardiography, in patients with dilated cardiomyopathy
Seshachar, C., & Shalini, G. G. (2026) · Annals of the National Academy of Medical Sciences (India) · doi:10.25259/anams_217_2025
Endocardial thickening in dilated cardiomyopathy associated with FHL2 variant: a case report
Wang, Y., Liang, L., Liu, L., Ren, J., & 王小仙 (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1841224
Cardiomyopathies in Pregnancy
Behnia, F., Clifford, C. C., Jain, S., Omere, C. I., Collins, A., & Pacheco, L. D. (2026) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000001058
A Common CD36 Variant and the Genetic Landscape of Dilated Cardiomyopathy in Individuals of African Ancestry
Challa, S. P., Biddinger, K. J., Abramowitz, S. A., Zheng, A., Mead, J. O., Judy, R., Jurgens, S. J., Gaziano, L., Wang, X., Choi, S. H., et al. (2026) · JAMA · doi:10.1001/jama.2026.18449
Dilated Cardiomyopathy: From Genetics to Cardiac MRI
Delcea, R.-D., Jurcut, R. O., Militaru, S., Adam, R. D., Onciul, S., Istrătoaie, O., Crăciun-Mirescu, A., Buzera, C., Afana, A. S., Militaru, C., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14112442
Clinical Correlates and Prognostic Value of Low QRS Voltages in Non-Ischemic Dilated Cardiomyopathy: A Retrospective Cohort Study
Li, T., Tian, T., Zhang, X., Gao, Z. T., Zhang, L., Gong, S., Deng, X., Qin, M., Zhang, Y., Qin, Z., et al. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm50413

Authors: McNally, E. M., & Mestroni, L.
Affiliations: Northwestern University (US)
ORCID: McNally, Elizabeth M.
Mestroni, Luisa
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2017-09-15
Volume: 121
Issue: 7
Pages: 731-748
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/circresaha.116.309396
PMC: PMC5626020
OpenAlex: W2755193453
Cited by: 786
References: 172
Citations by year: 2026: 63 · 2025: 89 · 2024: 93 · 2023: 123 · 2022: 89 · 2021: 105 · 2020: 95 · 2019: 79 · 2018: 43 · 2017: 4
FWCI: 8.52
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (UL1TR001422, UL1TR001082)
National Heart, Lung, and Blood Institute (R01HL122109, R01HL116906, R01HL147064, R01HL128075, R01HL061322, R01HL069071)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: dilated cardiomyopathy, non-ischemic cardiomyopathy, genetic testing, gene panel, cascade testing, arrhythmia risk, prognosis, genetic variants, pathophysiological mechanisms, cardiac morphology, early intervention
MeSH terms: Animals, Biopsy, Cardiomyopathy, Dilated, DNA Mutational Analysis, Genetic Markers, Humans, Mutation, Myocardium, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, Ventricular Function, Risk Assessment, Genetic Predisposition to Disease, Molecular Diagnostic Techniques, Cardiac Imaging Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dilated Cardiomyopathy: Genetic Determinants and Mechanisms

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks